SET/TAF-I Antikörper (Biotin)
-
- Target Alle SET/TAF-I (SET) Antikörper anzeigen
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SET/TAF-I Antikörper ist konjugiert mit Biotin
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Human
- Homologie
- Mouse,Rat,Dog,Cow,Horse,Chicken,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human SET
- Isotyp
- IgG
- Top Product
- Discover our top product SET Primärantikörper
-
anti-SET Nuclear Oncogene (SET) (AA 1-277) antibody
SET Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) antibodySET Reaktivität: Human WB, IHC, IF, IP Wirt: Kaninchen Monoclonal unconjugated
anti-SET Nuclear Oncogene (SET) (N-Term) antibodyVerified SET Reaktivität: Human WB, IHC, ELISA Wirt: Ziege Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) antibodySET Reaktivität: Human, Maus, Ratte IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) (AA 146-277) antibodySET Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) antibodySET Reaktivität: Human, Maus, Kaninchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) (AA 1-277) antibodySET Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal M1-F5 unconjugated
anti-SET Nuclear Oncogene (SET) (N-Term) antibodySET Reaktivität: Human WB, IF, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) (AA 147-235) antibodySET Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) antibodySET Reaktivität: Human, Maus, Ratte WB, FACS, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB: 1:100-1000, IHC-P: 1:100-500
Optimal working dilution should be determined by the investigator. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C for 12 months.
- Haltbarkeit
- 12 months
-
- Target
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
- Andere Bezeichnung
- Set (SET Produkte)
- Synonyme
- 2PP2A antikoerper, I2PP2A antikoerper, IGAAD antikoerper, IPP2A2 antikoerper, PHAPII antikoerper, TAF-I antikoerper, TAF-IBETA antikoerper, 2610030F17Rik antikoerper, 5730420M11Rik antikoerper, AA407739 antikoerper, I-2PP2A antikoerper, StF-IT-1 antikoerper, 2pp2a antikoerper, i2pp2a antikoerper, igaad antikoerper, ipp2a2 antikoerper, phapii antikoerper, set antikoerper, set-a antikoerper, set-b antikoerper, taf-ibeta antikoerper, wu:fb30g11 antikoerper, wu:fd16c08 antikoerper, SET nuclear proto-oncogene antikoerper, SET nuclear oncogene antikoerper, SET translocation antikoerper, SET nuclear proto-oncogene L homeolog antikoerper, SET nuclear proto-oncogene b antikoerper, SET antikoerper, Set antikoerper, LOC403555 antikoerper, set.L antikoerper, setb antikoerper
- Hintergrund
- Optional[synonyms]: SET_HUMAN, Protein SET, HLA-DR-associated protein II, Inhibitor of granzyme A-activated DNase (IGAAD), PHAPII, Phosphatase 2A inhibitor I2PP2A (I-2PP2A), Template-activating factor I (TAF-I), 2PP2A, IGAAD, MRD58, TAF-I, I2PP2A, IPP2A2, PHAPII, TAF-IBETA,
- Gen-ID
- 6418
- UniProt
- Q01105
- Pathways
- Apoptose
-
